Publications by authors named "Nathavitharana R"

Introduction: Most drug-resistant tuberculosis (DR-TB) occurs due to transmission of unsuspected or ineffectively treated DR-TB. The duration of treatment to stop person-to-person spread of DR-TB is uncertain. We evaluated the impact of novel regimens, including BPaL, on DR-TB transmission using the human-to-guinea pig (H-GP) transmission model.

View Article and Find Full Text PDF
Article Synopsis
  • - The systematic review focused on the effectiveness and impacts of respiratory isolation for pulmonary tuberculosis (TB), highlighting the lack of clear guidelines on how long isolation should last and inconsistent implementation across different settings.
  • - Researchers analyzed 17 studies, finding limited direct comparisons between isolation and no isolation. Some evidence suggests isolation might reduce transmission, but studies often combined it with other interventions and did not show significant effects post-treatment initiation.
  • - The review revealed significant negative consequences of isolation, including impacts on employment, education, and mental health, especially in marginalized groups, indicating that public health decisions must balance community transmission risks with the personal hardships faced by individuals with TB.
View Article and Find Full Text PDF

Determining the extent and duration of infectiousness of individuals with pulmonary tuberculosis (TB) is critical for various aspects of TB care, including decisions regarding isolation. Studies suggest considerable heterogeneity in infectiousness of people with pulmonary TB. Pre-treatment, measures of bacillary burden including sputum smear microscopy, culture time-to-positivity, and Xpert MTB/RIF cycle threshold (Ct) value, predict the risk of transmission to contacts.

View Article and Find Full Text PDF

INTRODUCTIONClosing the TB diagnostic gap is an urgent priority, for which non-sputum-based tests are needed. We evaluated the diagnostic accuracy of Aeonose, an exhaled breath test (EBT), as a TB triage test.METHODSPatients with cough or TB risk factors admitted to a tertiary hospital in Lima, Peru, were prospectively enrolled and underwent EBT.

View Article and Find Full Text PDF

Background: Anticipated, internal, and enacted stigma are major barriers to tuberculosis (TB) care engagement and directly impact patient well-being. Unfortunately, targeted stigma interventions are lacking. We aimed to co-develop a person-centred stigma intervention with TB-affected community members and health workers in South Africa.

View Article and Find Full Text PDF

Background: Translating health policy into effective implementation is a core priority for responding effectively to the tuberculosis (TB) crisis. The national TB Recovery Plan was developed in response to the negative impact that the COVID-19 pandemic had on TB care in South Africa. We aimed to explore the implementation of the TB Recovery Plan and develop recommendations for strengthening accountability for policy implementation for this and future TB policies.

View Article and Find Full Text PDF

Background: Though tuberculosis (TB)-related stigma is a recognized barrier to care, interventions are lacking, and gaps remain in understanding the drivers and experiences of TB-related stigma. We undertook community-based mixed methods stigma assessments to inform stigma intervention design.

Methods: We adapted the Stop TB Partnership stigma assessment tool and trained three peer research associates (PRAs; two TB survivors, one community health worker) to conduct surveys with people with TB (PWTB,  = 93) and caregivers of children with TB ( = 24) at peri-urban and rural clinic sites in Khayelitsha, Western Cape, and Hammanskraal, Gauteng Province, South Africa.

View Article and Find Full Text PDF
Article Synopsis
  • Improving access to tuberculosis testing is crucial to combat the disease, as a significant number of cases go undiagnosed despite advances in rapid diagnostics.
  • Over 3.1 million out of an estimated 10.6 million global tuberculosis cases in 2022 were not diagnosed, highlighting a major gap that improvements in test accuracy alone cannot close.
  • Diagnostic yield, the efficacy of tests in identifying tuberculosis in various populations, especially those who can't produce sputum, must be prioritized in test evaluations to enhance effective coverage and improve overall clinical care.
View Article and Find Full Text PDF

Background: India accounts for about one-quarter of people contracting tuberculosis (TB) disease annually and nearly one-third of TB deaths globally. Many Indians do not navigate all care cascade stages to receive TB treatment and achieve recurrence-free survival. Guided by a population/exposure/comparison/outcomes (PECO) framework, we report findings of a systematic review to identify factors contributing to unfavorable outcomes across each care cascade gap for TB disease in India.

View Article and Find Full Text PDF
Article Synopsis
  • Anticipated, internal, and enacted stigma surrounding tuberculosis (TB) significantly hinders patient care and well-being, prompting the need for targeted interventions co-developed with TB-affected individuals and health workers in South Africa.
  • Utilizing community-based participatory research, discussions were held with 87 participants in Khayelitsha to identify stigma drivers and potential solutions, emphasizing the importance of lived experiences of TB survivors in crafting effective messaging.
  • Recommended intervention strategies included education and support at various levels, such as counselling at the individual level, support clubs at the interpersonal level, training for health workers, community awareness events, and school curricula integration to combat stigma.
View Article and Find Full Text PDF

Tuberculosis (TB) transmission in healthcare facilities is common in high-incidence countries. Yet, the optimal approach for identifying inpatients who may have TB is unclear. We evaluated the diagnostic accuracy of qXR (Qure.

View Article and Find Full Text PDF

Background: Though TB-related stigma is a recognized barrier to care, interventions are lacking and gaps remain in understanding the drivers and experiences of TB-related stigma. We undertook community-based mixed methods stigma assessments to inform stigma intervention design.

Methods: We adapted the Stop TB Partnership stigma assessment tool, and trained three peer research associates (PRAs; two TB survivors, one community health worker) to conduct surveys with people with TB (PWTB, n=93) and caregivers of children with TB (n=24) at peri-urban and rural clinic sites in Khayelitsha, Western Cape, and Hammanskraal, Gauteng Province, South Africa.

View Article and Find Full Text PDF

Introduction: Tuberculosis (TB) transmission in healthcare facilities is common in high-incidence countries. Yet, the optimal approach for identifying inpatients who may have TB is unclear. We evaluated the diagnostic accuracy of qXR (Qure.

View Article and Find Full Text PDF

Stigma is a critical barrier for TB care delivery; yet data on stigma reduction interventions is limited. This review maps the available literature on TB stigma reduction interventions, using the Health Stigma and Discrimination framework and an implementation analysis to identify research gaps and inform intervention design. Using search terms for TB and stigma, we systematically searched PubMed, EMBASE and Web of Science.

View Article and Find Full Text PDF

Female genital tuberculosis (FGTB) is an important cause of morbidity and infertility worldwide. most commonly spreads to the genital tract from a focus elsewhere in the body and affects the bilateral fallopian tubes and/or endometrium. Many patients with FGTB have indolent disease and are only diagnosed after evaluation for infertility.

View Article and Find Full Text PDF

Background: High rates of tuberculosis (TB) transmission occur in hospitals in high-incidence countries, yet there is no validated way to evaluate the impact of hospital design and function on airborne infection risk. We hypothesized that personal ambient carbon dioxide (CO2) monitoring could serve as a surrogate measure of rebreathed air exposure associated with TB infection risk in health workers (HWs).

Methods: We analyzed baseline and repeat (12-month) interferon-γ release assay (IGRA) results in 138 HWs in Cape Town, South Africa.

View Article and Find Full Text PDF

Rapid, accurate, sputum-free tests for tuberculosis (TB) triage and confirmation are urgently needed to close the widening diagnostic gap. We summarise key technologies and review programmatic, systems, and resource issues that could affect the impact of diagnostics. Mid-to-early-stage technologies like artificial intelligence-based automated digital chest X-radiography and capillary blood point-of-care assays are particularly promising.

View Article and Find Full Text PDF

Tuberculosis (TB) is the leading cause of death in people living with HIV (PLHIV) globally, causing 208,000 deaths in PLHIV in 2019. PLHIV have an 18-fold higher risk of TB, and HIV/TB mortality is highest in inpatient facilities, compared with primary care and community settings. Here we discuss challenges and potential mitigating solutions to address TB-related mortality in adults with HIV.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) care cascade analyses show large gaps at early stages, including care-seeking and diagnostic evaluation, where promising interventions to decrease attrition are urgently needed. Person-centered care is prioritized in the World Health Organization's End TB strategy; yet little is known about how it is delivered and can be optimized. Recommendations for counselling, a core component of person-centered care, are largely limited to its role in improving TB treatment adherence.

View Article and Find Full Text PDF

Objective: To evaluate the effect of the FAST (Find cases Actively, Separate safely, Treat effectively) strategy on time to tuberculosis diagnosis and treatment for patients at a general hospital in a tuberculosis-endemic setting.

Design: Prospective cohort study with historical controls.

Participants: Patients diagnosed with pulmonary tuberculosis during hospitalization at Hospital Nacional Hipolito Unanue in Lima, Peru.

View Article and Find Full Text PDF
Article Synopsis
  • Tuberculosis is a major cause of hospital admissions and high mortality rates in individuals living with HIV, highlighting the need for effective diagnostic methods.
  • The Alere Determine TB LAM Ag test (AlereLAM) is a point-of-care diagnostic tool endorsed by the WHO, and this review evaluates its impact on mortality and key health outcomes in HIV patients.
  • The review incorporates data from various medical databases and focuses on randomized controlled trials comparing AlereLAM with other diagnostic methods for tuberculosis in adults with HIV.
View Article and Find Full Text PDF

Background: Healthcare workers (HWs) have at least twice the risk of tuberculosis (TB) compared to the general population. There is growing emphasis on latent TB infection (LTBI) in high-risk populations. Yet we know little about HWs' perspectives of LTBI testing and treatment to inform implementation in high-incidence settings.

View Article and Find Full Text PDF